בודסון 3 מג כמוסות
rafa laboratories ltd - budesonide - קפסולות - budesonide 3 mg - budesonide - budesonide - for the induction and maintenance of remission in patients with mild to moderate crohn's disease affecting the ileum and/or the ascending colon.
רפאסאל 500 מג קפליות
rafa laboratories ltd - mesalazine - caplets - mesalazine 500 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.
רפאסאל 500 מג פתילות
rafa laboratories ltd - mesalazine - פתילות - mesalazine 500 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.
רפאסאל 1 גרם קפליות
rafa laboratories ltd - mesalazine - caplets - mesalazine 1000.0 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.
רפאסאל 1 גרם פתילות
rafa laboratories ltd - mesalazine - פתילות - mesalazine 1000 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.
רזין
cts chemical industries ltd, israel - phentermine as resinate - קפסולות - phentermine as resinate 15 mg - phentermine - phentermine - for the treatment of severe obesity that has not responded to an appropriate diet - a minimal body mass index of 30 kg/m2 is required.
קראון 10000
abbott medical laboratories ltd, israel - pancreatin - קפסולות - pancreatin 150 mg - multienzymes (lipase, protease etc.) - multienzymes (lipase, protease etc.) - pancreatic exocrine insufficiency.
קראון 25000
abbott medical laboratories ltd, israel - pancreatin - קפסולות - pancreatin 300 mg - multienzymes (lipase, protease etc.) - multienzymes (lipase, protease etc.) - for the treatment of pancreatic exocrine insufficiency.
ג'נואט 50 מג500 מג
merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - טבליה - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 500 mg - metformin - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.
ג'נואט 50 מג850 מג
merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - טבליה - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 850 mg - metformin - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.